Recent AQST News
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 08:47:19 PM
- Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences • GlobeNewswire Inc. • 11/12/2024 01:00:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/08/2024 10:31:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:01:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 09:01:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 09:40:49 PM
- Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/04/2024 09:36:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2024 12:05:43 PM
- Aquestive Therapeutics to Present Subsequent Analysis of Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Demonstrating Comparable PK and PD Data to Epinephrine Injection Regardless of Variable Placement or Intraoral Movement at American College • GlobeNewswire Inc. • 10/25/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2024 12:06:00 PM
- Aquestive Therapeutics Announces Positive Topline Results from Oral Allergy Syndrome (OAS) Challenge Study for Anaphylm™ (epinephrine) Sublingual Film • GlobeNewswire Inc. • 10/24/2024 12:00:00 PM
- Aquestive Therapeutics to Report Third Quarter 2024 Financial Results and Recent Business Highlights on November 4 and Host Conference Call on November 5 at 8:00 a.m. ET • GlobeNewswire Inc. • 10/21/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 09:16:29 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 10/02/2024 06:16:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 12:46:44 PM
- Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day • GlobeNewswire Inc. • 09/27/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 12:56:17 PM
- Aquestive Therapeutics to Hold Virtual Investor Day to Provide Pipeline Updates on September 27th • GlobeNewswire Inc. • 09/09/2024 12:15:00 PM
- Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences • GlobeNewswire Inc. • 08/22/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 12:08:37 PM
- Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates Expected Timing for NDA Filing of Anaphylm™ • GlobeNewswire Inc. • 08/14/2024 12:00:00 PM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM